311 related articles for article (PubMed ID: 21966264)
21. Shifting Fitness and Epistatic Landscapes Reflect Trade-offs along an Evolutionary Pathway.
Steinberg B; Ostermeier M
J Mol Biol; 2016 Jul; 428(13):2730-43. PubMed ID: 27173379
[TBL] [Abstract][Full Text] [Related]
22. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
Winkler ML; Bonomo RA
Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
[TBL] [Abstract][Full Text] [Related]
23. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
[TBL] [Abstract][Full Text] [Related]
24. Adaptive Processes Change as Multiple Functions Evolve.
Mira PM; Østman B; Guzman-Cole C; Sindi S; Barlow M
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468488
[TBL] [Abstract][Full Text] [Related]
25. Unraveling the causes of adaptive benefits of synonymous mutations in TEM-1 β-lactamase.
Zwart MP; Schenk MF; Hwang S; Koopmanschap B; de Lange N; van de Pol L; Nga TTT; Szendro IG; Krug J; de Visser JAGM
Heredity (Edinb); 2018 Nov; 121(5):406-421. PubMed ID: 29967397
[TBL] [Abstract][Full Text] [Related]
26. Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli.
Caniça MM; Lu CY; Krishnamoorthy R; Paul GC
J Mol Evol; 1997 Jan; 44(1):57-65. PubMed ID: 9010136
[TBL] [Abstract][Full Text] [Related]
27. Environmental changes bridge evolutionary valleys.
Steinberg B; Ostermeier M
Sci Adv; 2016 Jan; 2(1):e1500921. PubMed ID: 26844293
[TBL] [Abstract][Full Text] [Related]
28. Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase.
Barlow M; Hall BG
Genetics; 2002 Mar; 160(3):823-32. PubMed ID: 11901104
[TBL] [Abstract][Full Text] [Related]
29. Pervasive Pairwise Intragenic Epistasis among Sequential Mutations in TEM-1 β-Lactamase.
Gonzalez CE; Ostermeier M
J Mol Biol; 2019 May; 431(10):1981-1992. PubMed ID: 30922874
[TBL] [Abstract][Full Text] [Related]
30. The genetic code constrains yet facilitates Darwinian evolution.
Firnberg E; Ostermeier M
Nucleic Acids Res; 2013 Aug; 41(15):7420-8. PubMed ID: 23754851
[TBL] [Abstract][Full Text] [Related]
31. Modified Antibiotic Adjuvant Ratios Can Slow and Steer the Evolution of Resistance: Co-amoxiclav as a Case Study.
Allen RC; Brown SP
mBio; 2019 Sep; 10(5):. PubMed ID: 31530673
[TBL] [Abstract][Full Text] [Related]
32. Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases.
Martínez-García L; González-Alba JM; Baquero F; Cantón R; Galán JC
mBio; 2018 May; 9(3):. PubMed ID: 29739906
[TBL] [Abstract][Full Text] [Related]
33. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
Jacquier H; Marcadé G; Raffoux E; Dombret H; Woerther PL; Donay JL; Arlet G; Cambau E
J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Antibiotic Resistance Evolution by Growth Measurement of All Proximal Mutants of Beta-Lactamase.
Feng S; Wu Z; Liang W; Zhang X; Cai X; Li J; Liang L; Lin D; Stoesser N; Doi Y; Zhong LL; Liu Y; Xia Y; Dai M; Zhang L; Chen X; Yang JR; Tian GB
Mol Biol Evol; 2022 May; 39(5):. PubMed ID: 35485492
[TBL] [Abstract][Full Text] [Related]
35. Experimental evolution of gene duplicates in a bacterial plasmid model.
Holloway AK; Palzkill T; Bull JJ
J Mol Evol; 2007 Feb; 64(2):215-22. PubMed ID: 17211548
[TBL] [Abstract][Full Text] [Related]
36. Mutations Utilize Dynamic Allostery to Confer Resistance in TEM-1 β-lactamase.
Modi T; Ozkan SB
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501088
[TBL] [Abstract][Full Text] [Related]
37. Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitor.
Russ D; Glaser F; Shaer Tamar E; Yelin I; Baym M; Kelsic ED; Zampaloni C; Haldimann A; Kishony R
Nat Commun; 2020 Apr; 11(1):2029. PubMed ID: 32332717
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW
Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067
[TBL] [Abstract][Full Text] [Related]
39. Evolutionary potential of an RNA virus.
Makeyev EV; Bamford DH
J Virol; 2004 Feb; 78(4):2114-20. PubMed ID: 14747576
[TBL] [Abstract][Full Text] [Related]
40. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
Chouchani C; Ben-Achour N; M'charek A; Belhadj O
C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
